Biotech Values

[Whalatane]

M read the ICER report on Vascepa. Health providers will SAVE $ putting these patients on Vascepa

The health care costs of those on this label averages $5k a yr . Vascepa cost to provider is $1,600’roughly a yr

Follow up studies by Dr Bhatt show NNT dropping into single digits

Vascepa scripts will explode IMHO ( if marketed aggressively ) as it’s seen as “ natural “

Something wrong with mgt if they don’t get this up to $1B in annual sales by end of 2020
JMO
Kiwi
On the drug and own the stock